TP53 and prostate cancer: Up-regulation of miR-125b is not only observed in pancreatic cancer [26], prostate cancer [27], and acute myeloid leukemia [28], but also promotes cancer cell proliferation and suppresses p53-dependent apoptosis in human neuroblastoma cells [29].